Insider Selling: Privia Health Group (NASDAQ:PRVA) CEO Sells 21,440 Shares of Stock

by · The Markets Daily

Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) CEO Parth Mehrotra sold 21,440 shares of the company’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $23.15, for a total value of $496,336.00. Following the completion of the transaction, the chief executive officer directly owned 385,794 shares in the company, valued at $8,931,131.10. This represents a 5.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Parth Mehrotra also recently made the following trade(s):

  • On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total value of $960,097.14.

Privia Health Group Stock Down 3.6%

Shares of NASDAQ PRVA traded down $0.83 during mid-day trading on Tuesday, hitting $22.47. 1,025,433 shares of the company traded hands, compared to its average volume of 813,068. Privia Health Group, Inc. has a 1 year low of $18.77 and a 1 year high of $26.51. The stock has a market capitalization of $2.78 billion, a price-to-earnings ratio of 132.18, a PEG ratio of 1.49 and a beta of 0.82. The business has a 50 day moving average of $23.03 and a two-hundred day moving average of $23.60.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The firm had revenue of $541.17 million for the quarter, compared to analysts’ expectations of $516.61 million. During the same quarter last year, the business posted $0.21 EPS. Privia Health Group’s revenue was up 17.4% on a year-over-year basis. As a group, research analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on PRVA shares. Wolfe Research set a $31.00 price objective on shares of Privia Health Group in a research report on Tuesday, January 6th. Canaccord Genuity Group raised their target price on Privia Health Group from $34.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. Piper Sandler reiterated an “overweight” rating and set a $36.00 price target on shares of Privia Health Group in a report on Thursday, February 26th. Jefferies Financial Group reissued a “buy” rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, February 26th. Finally, Citigroup lowered their target price on Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a research note on Tuesday, March 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $31.00.

Get Our Latest Stock Analysis on Privia Health Group

Institutional Investors Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Bayban acquired a new position in Privia Health Group in the fourth quarter worth approximately $26,000. Hantz Financial Services Inc. lifted its stake in Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after acquiring an additional 926 shares during the last quarter. Global Retirement Partners LLC grew its position in Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after acquiring an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board increased its stake in shares of Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Kestra Advisory Services LLC acquired a new position in shares of Privia Health Group during the 4th quarter worth $93,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.

Recommended Stories